Normal prions as a new target of cobalamin (vitamin B12) in rat central nervous system

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 3, 2013, Pages 601-606

  Scalabrino, Giuseppe ^a   Veber, Daniela ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cerebrospinal fluid; Cobalamin deficiency; Epidermal growth factor; Normal prion protein; Spinal cord; Tumor necrosis factor

Indexed keywords

COBALAMIN; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; OCTAPEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASTROCYTOSIS; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DUODENUM; MOUSE; NEUROPATHY; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; RAT; SPINAL CORD;

ANIMALS; CENTRAL NERVOUS SYSTEM; COPPER; EPIDERMAL GROWTH FACTOR; PRIONS; RATS; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 84882316618     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0474     Document Type: Conference Paper

References (41)

1. Pant SH, Asbury AK, Richardson EP. The myelopathy of pernicious anemia: a neuropathological reappraisal. Acta Neurol Scand 1968;44(Suppl 35):1-36.
2. Andrés E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, et al. Vitamin B 12 (cobalamin) deficiency in elderly patients. CMAJ 2004;171:251-9.
3. Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, Podell ER, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988;318:1720-8.
4. Carmel R. Pernicious anemia. The expected findings of very low serum cobalamin levels, anemia, and macrocytosis are often lacking. Arch Int Med 1988;148:1712-4.
5. Scalabrino G, Veber D, Mutti E. Experimental and clinical evidence of the role of cytokines and growth factors in the pathogenesis of acquired cobalamin-deficient leukoneuropathy. Brain Res Rev 2008;59:42-54.
6. 12 (cobalamin) neurotrophism in adult central nervous system: lessons learned from its deficiency. Prog Neurobiol 2009;88:203-20.
7. Nishida N, Tremblay P, Sugimoto T, Shigematsu K, Shirabe S, Petromilli C, et al. A mouse prion protein transgene rescues mice deficient for the prion protein gene from Purkinje cell degeneration and demyelination. Lab Invest 1999;79:689-97.
8. Sakaguchi S. Molecular biology of prion protein and its first homologous protein. J Med Invest 2007;54:211-23.
9. Solomon IH, Schepker JA, Harris DA. Prion neurotoxicity: insights from prion protein mutants. Curr Issues Mol Biol 2010;12:51-61.
10. Baumann F, Tolnay M, Brabeck C, Pahnke J, Kloz U, Niemann HH, et al. Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J 2007;26:538-47.
11. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008;88:673-728.
12. Aguzzi A, Baumann F, Bremer J. The prion's elusive reason for being. Annu Rev Neurosci 2008;31:439-77.
13. c. J Neurosci 2005;25:4879-88.
14. Kovacs GG, Budka H. Prion diseases: from protein to cell pathology. Am J Pathol 2008;172:555-65.
15. Wadsworth JD, Collinge J. Molecular pathology of human prion disease. Acta Neuropathol 2011;121:69-77.
16. Kuwahara C, Kubosaki A, Nishimura T, Nasu Y, Nakamura Y, Saeki K, et al. Enhanced expression of cellular prion protein gene by insulin or nerve growth factor in immortalized mouse neuronal precursor cell lines. Biochem Biophys Res Commun 2000;268:763-6.
17. c expression: nerve growth factor (NGF) activates the prion gene promoter through the MEK1 pathway in PC12 cells. Neurosci Lett 2006;400:58-62.
18. Sauer H, Wefer K, Vetrugno V, Pocchiari M, Gissel C, Sachinidis A, et al. Regulation of intrinsic prion protein by growth factors and TNF-α: the role of intracellular reactive oxygen species. Free Radic Biol Med 2003;35:586-94.
19. Kim JI, Ju WK, Choi JH, Choi E, Carp RI, Wisniewski HM, et al. Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice. Mol Brain Res 1999;73:17-27.
20. Julius C, Heikenwalder M, Schwarz P, Marcel A, Karin M, Prinz M, et al. Prion propagation in mice lacking central nervous system NF-kappaB signalling. J Gen Virol 2008;89:1545-50.
21. Campbell IL, Eddleston M, Kemper P, Oldstone MB, Hobbs MV. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J Virol 1994;68:2383-7.
22. Williams AE, Van Dam A-M, Man-A-Hing WK, Berkenbosch F, Eikelenboom P, Fraser H. Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice. Brain Res 1994;654:200-6.
23. c, PrPc-mRNA and copper levels in rat central nervous system. Exp Neurol 2012;233:380-90.
24. Mitteregger G, Vosko M, Krebs B, Xiang W, Kohlmannsperger V, Nölting S, et al. The role of the octarepeat region in neuroprotective function of the cellular prion protein. Brain Pathol 2007;17:174-83.
25. Li A, Piccardo P, Barmada SJ, Ghetti B, Harris DA. Prion protein with an octapeptide insertion has impaired neuroprotective activity in transgenic mice. EMBO J 2007;26:2777-85.
26. Polymenidou M, Moos R, Scott M, Sigurdson C, Shi Y-Z, Yajima B, et al. The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS One 2008;3:e3872.
27. Kalra S, Ahuja R, Mutti E, Veber D, Seetharam S, Scalabrino G, et al. Cobalamin-mediated regulation of transcobalamin receptor levels in rat organs. Arch Biochem Biophys 2007;463:128-32.
28. Buccellato FR, Miloso M, Braga M, Nicolini G, Morabito A, Pravettoni G, et al. Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-α-mediated. FASEB J 1999;13:297-304.
29. 12 (cobalamin) in the rat central nervous system. J Neuropathol Exp Neurol 2000;59:808-14.
30. Tsiroulnikov K, Chobert JM, Haertlé T. Copper-dependent degradation of recombinant ovine prion protein. FEBS J 2006;273:1959-65.
31. Owen F, Poulter M, Collinge J, Leach M, Lofthouse R, Crow TJ, et al. A dementing illness associated with a novel insertion in the prion protein gene. Mol Brain Res 1992;13:155-7.
32. Krasemann S, Zerr I, Weber T, Poser S, Kretzschmar H, Hunsmann G, et al. Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. Mol Brain Res 1995;34:173-6.
33. Mead S. Prion disease genetics. Eur J Hum Genet 2006;14:273-81.
34. Mead S, Webb TE, Campbell TA, Beck J, Linehan JM, Rutherfoord S, et al. Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129. Neurology 2007;69:730-8.
35. Chiesa R, Harris DA. Prion diseases: what is the neurotoxic molecule? Neurobiol Dis 2001;8:743-63.
36. Flechsig E, Shmerling D, Hegyi I, Raeber AJ, Fischer M, Cozzio A, et al. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 2000;27:399-408.
37. Cohen FE, Prusiner SB. Structural studies of prion proteins. In: Prusiner SB, editor. Prion biology and diseases. New York: Cold Spring Harbor Laboratory Press, 1999:191-228.
38. c and its homologue Dpl. Trends Neurosci 2002;25:150-4.
39. Prusiner SB. An introduction to prion biology and diseases. In: Prusiner SB, editor. Prion biology and diseases. New York: Cold Spring Harbor Laboratory Press, 1999:1-66.
40. Pradines E, Loubet D, Mouillet-Richard S, Manivet P, Launay JM, Kellermann O, et al. Cellular prion protein coupling to TACE-dependent TNF-α shedding controls neurotransmitter catabolism in neuronal cells. J Neurochem 2009;110:912-23.
41. 12. J Biol Chem 2003;278:20778-84.